Lisata Therapeutics logo
LSTALisata Therapeutics
Trade LSTA now
Lisata Therapeutics primary media

About Lisata Therapeutics

Lisata Therapeutics (NASDAQ:LSTA) is dedicated to developing innovative therapeutics for the treatment of cancer and other serious diseases. With a focus on crafting solutions that precisely target disease mechanisms, Lisata is at the forefront of creating next-generation treatments. Their projects span from early-stage research to advanced clinical trials, aiming to transform patient care and outcomes. Objectives include accelerating the development of their pipeline projects, expanding their research into new therapeutic areas, and establishing partnerships to enhance their reach and capabilities. Through relentless innovation and a commitment to excellence, Lisata Therapeutics strives to improve the quality of life for patients worldwide.

What is LSTA known for?

Snapshot

Public US
Ownership
1980
Year founded
25
Employees
New Jersey, United States
Head office
1 of 2
US Rank
Unknown
Sector
N/A
Sector rank
Loading Map...

Operations

All Locations
United States

Produtos e/ou serviços de Lisata Therapeutics

  • Developing a unique delivery system for solid tumor treatment, leveraging targeted payload release.
  • Advancing a novel oncology pipeline with proprietary technology aimed at improving cancer treatment outcomes.
  • Creating personalized medicine solutions to enhance efficacy in cancer therapies.
  • Innovating in drug delivery platforms to minimize side effects and optimize therapeutic impact.
  • Collaborating on research projects with leading institutions to accelerate groundbreaking cancer treatments.
  • Expanding into biotechnology services to support drug development and clinical trials for oncology.

equipe executiva do Lisata Therapeutics

  • Dr. David J. Mazzo B.A. (Hons), B.Sc. (Hons.), M.Sc., Ph.D.President, CEO & Director
  • Mr. James NiscoSenior VP of Finance, Treasurer, CAO & Principal Financial and Accounting Officer
  • Dr. Kristen K. Buck M.D.Executive VP of R&D and Chief Medical Officer
  • Mr. Tariq ImamSenior VP of Business Development & Operations and General Counsel
  • Mr. Gregory S. BerkinChief Information & Data Protection Officer
  • Mr. John D. MendittoVice President of Investor Relations & Corporate Communications
  • Dr. William K. Sietsema Ph.D.Vice President of Global Regulatory Affairs

Connect with us

Disclaimer

Grafa is not a financial advisor. You should seek independent, legal, financial, taxation or other advice that relate to your unique circumstances.

Grafa is not liable for any loss caused, whether due to negligence or otherwise arising from the use of or reliance on the information provided directly or indirectly, by use of this platform.